Transcriptional regulation of apolipoprotein A-I gene expression by the nuclear receptor RORalpha

Since elevated concentrations of plasma high density lipoprotein (HDL) and its major apolipoprotein (apo), apoA-I, confer protection against atherosclerosis, considerable research efforts have focussed on the identification of factors regulating apoA-I gene expression in an attempt to increase its p...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of biological chemistry Vol. 272; no. 36; p. 22401
Main Authors Vu-Dac, N. (INSERM, Institut Pasteur de Lille, Lille, France.), Gervois, P, Grotzinger, T, Vos, P. de, Schoonjans, K, Fruchart, J.C, Auwerx, J, Mariani, J, Tedgui, A, Staels, B
Format Journal Article
LanguageEnglish
Published United States 05.09.1997
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Since elevated concentrations of plasma high density lipoprotein (HDL) and its major apolipoprotein (apo), apoA-I, confer protection against atherosclerosis, considerable research efforts have focussed on the identification of factors regulating apoA-I gene expression in an attempt to increase its production. Nuclear receptors are interesting candidates because they are transcription factors whose activity is ligand-dependent. In the present study we identified the orphan receptor RORalpha1 as an activator of apoA-I gene transcription. In apoA-I-expressing intestinal Caco-2 cells, overexpression of the RORalpha1, but not the RORalpha2 or RORalpha3 isoforms, increased rat apoA-I gene transcription. Deletion and site-directed mutagenesis experiments identified a functional ROR-responsive element (RORE) in the rat and mouse apoA-I gene promoters, which overlaps with the TATA box. Gel shift experiments indicated that this RORE binds the RORalpha1 isoform, but not the RORalpha2 or RORalpha3 isoforms. Furthermore, compared with wild type mice, apoA-I mRNA levels were significantly lower in small intestines of staggerer mice homozygous for a deletion in the RORalpha gene. In addition, reverse transcriptase-polymerase chain reaction analysis revealed the expression of RORalpha in small intestinal epithelium and in Caco-2 cells. These data indicate a novel, physiological role for RORalpha1 in the regulation of genes involved in lipid and lipoprotein metabolism and possibly in the development of metabolic diseases, such as atherosclerosis.
Bibliography:S20
1997081792
S30
ISSN:0021-9258
1083-351X